BECN1 and hepatocellular carcinoma: Treatment of HCC cells with MG increased intracellular ROS and superoxide levels, upregulated ATG5-ATG12 complex and Beclin-1, and converted LC3-I to LC3-II, all of which are essential to the induction of autophagy of HCC cells.